CN1413722A - Chinese patent drug for treating thrombus obliterating angiitis - Google Patents
Chinese patent drug for treating thrombus obliterating angiitis Download PDFInfo
- Publication number
- CN1413722A CN1413722A CN02135739A CN02135739A CN1413722A CN 1413722 A CN1413722 A CN 1413722A CN 02135739 A CN02135739 A CN 02135739A CN 02135739 A CN02135739 A CN 02135739A CN 1413722 A CN1413722 A CN 1413722A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese patent
- medicine
- blood
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
A Chinese patent medicine for treating thromboangititis obliterans is prepared from 24 Chinese-medicinal materials including astragalus root, safflower, peach kernel, Chuan-xiong, red peony root, etc. Its advantages are high effective rate (95%), high cure rate (50%), low cost and no toxic by-effect.
Description
The present invention relates to a kind of Chinese patent medicine, specifically a kind of Chinese patent medicine for the treatment of thromboangiitis obliterans.
Thromboangiitis obliterans is that a kind of limbs disability rate is very high, and in can causing, the chronic nonsuppurative inflammation of petty action vein blood vessel obturation, mainly involve in the extremity, small artery.Clinical manifestation is afraid of cold for suffering from the limb far-end, feeling of numbness is arranged, foot and shank have the pain of delocalization, continuing intermittent claudication then occurs, and toes have rest pain, the aggravation at night, it is purple dark-coloured that the toe-end temperature reduces, bleaches even is, be the able-bodied disease of a kind of serious harm human body, the only a few severe patient even the amputation of need going bring great psychic pain and financial burden to the patient.The present doctor trained in Western medicine of thromboangiitis obliterans disease still there are not active drug and method treatment, vasodilation gallbladder ginseng, kallidinogenase etc., it is invalid to have proved ischemic acroesthesia clinically.Blood vessel lytic agent urokinase, streptokinase etc. also can only be effective to acute thrombotic vascular occlusion, and be invalid to chronic occlusion, and toxic and side effects is big, can not effect a radical cure, treatment cost height.
The object of the present invention is to provide a kind of heat-clearing and toxic substances removing, the network blood of regulating the flow of vital energy, warming YANG dispelling wind and removing obstruction in the collateral, make the cold-evil be able to temperature and loose, pyretic toxicity is able to removing summer-heat, and QI-blood circulation is unobstructed, and no pain, to have no side effect, treat cost low, and the Chinese patent medicine of treatment thromboangiitis obliterans.
Solution of the present invention is based on motherland's medical science to pathogenetic understanding of thromboangiitis obliterans and Therapeutic Principle.Study with reference to modern pharmacology, select for use heat-clearing and toxic substances removing, promoting blood circulation to remove obstruction in the collateral class medicine formulated, existing blood viscosity lowering, improve the effect of hemorheology, the LBF of increasing amount is arranged again, improve the limbs microcirculation, promote the effect of side limb circulation, can obviously improve suffer from that limb is heavy, pain, diabrosis, symptom such as rot, to reach the effect of curing thromboangiitis obliterans.
It is formulated by pure Chinese medicine that the present invention treats the Chinese patent medicine of thromboangiitis obliterans, so without any side effects to human body.
The present invention treat the thromboangiitis obliterans Chinese patent medicine formula and weight proportion as follows:
Radix Astragali 30-50 part, Agkistrodon 6-15 part, Scorpio 2-6 part, Rhizoma Dioscoreae Bulbiferae 10-20 part,
Flos Carthami 6-12 part, Semen Persicae 12-20 part, Rhizoma Chuanxiong 10-15 part, Radix Paeoniae Rubra 10-15 part,
Flos Lonicerae 20-30 part, Placenta Hominis 15-20 part, Radix Angelicae Sinensis 10-30 part, river cattle sunset 10-12 part,
Hirudo 3-6 part, Radix Glycyrrhizae 9-12 part, Radix Aconiti Lateralis Preparata 6-8 part, Radix Scrophulariae 10-20 part,
Radix Salviae Miltiorrhizae 20-40 part, Semen Coicis 20-30 part, Caulis Spatholobi 12-15 part, Eupolyphaga Seu Steleophaga 12-15 part,
Sanguis Draxonis 6-9 part, Olibanum 5-9 part, Herba Violae 20-40 part, Herba Patriniae 12-20 part,
The above-mentioned prescription treatment thrombosis of using Chinese patent medicine of the present invention closes cold vasculitis, and curative effect is obvious, and it is rapid to eliminate symptom, and taking convenience has no side effect, and the treatment cost is low, effective percentage 95%, obvious effective rate 77.8%, cure rate 50%.
The antipyretic and antidotal type medicine is Flos Lonicerae, Semen Coicis, Herba Violae, Rhizoma Dioscoreae Bulbiferae, Herba Patriniae, Radix Scrophulariae in the Chinese patent medicine of the present invention; The class of invigorating blood circulation medicine is: Flos Carthami, Radix Paeoniae Rubra, Semen Persicae, Rhizoma Chuanxiong, Radix Angelicae Sinensis, river Niu Xi, Hirudo, Radix Salviae Miltiorrhizae, Caulis Spatholobi, Eupolyphaga Seu Steleophaga, Olibanum; Dispelling, collateral-activating class medicine is: Agkistrodon, Scorpio; Warming YANG class medicine is: Radix Aconiti Lateralis Preparata, Placenta Hominis; Promoting tissue regeneration and ulcer healing class medicine is a Sanguis Draxonis; QI invigorating class medicine is the Radix Astragali.
Prove according to Traditional Chinese medical theory and modern medicine study, the nature and flavor of various composition medicines in the Chinese patent medicine of the present invention, return through and useful effect as follows:
Flos Lonicerae: nature and flavor are sweet, cold, return lung, stomach, large intestine channel, and heat-clearing and toxic substances removing contains bios, reseda flavin etc., has broad-spectrum antibacterial action.(1. seeing " Chinese medicine summary " 90 pages, Yu Daxiang chief editor, in June, 1985, People's Health Publisher)
Herba Violae: nature and flavor hardship, suffering, cold, GUIXIN, Liver Channel, heat-clearing and toxic substances removing contains glycoside, flavonoid etc., and broad-spectrum antibacterial action is arranged.(the same 1. 91-92 page or leaf)
Semen Coicis: nature and flavor are sweet, light, be slightly cold, and return spleen, lung, kidney channel, and spleen invigorating eliminating dampness by diuresis, clearing away heat and discharging pus contain Semen Coicis oil, the heart of a lotus seed like the core ester etc.(the same 1. 106 pages)
Herba Patriniae: nature and flavor suffering, hardship, be slightly cold, return stomach, large intestine, Liver Channel, heat-clearing and toxic substances removing, the pain that disappears evacuation of pus, stasis-dispelling and pain-killing.(2. see " Chinese materia medica " 61 pages, insult a principle chief editor, nineteen eighty-three December, Shanghai science tech publishing house)
Radix Scrophulariae: nature and flavor hardship, one-tenth, cold, nourishing YIN and clearing away heat, the detoxifcation softening the hard mass contains harpagoside, alkaloid etc., and bacillus pyocyaneus is had inhibitory action.(the same 1. 94 pages)
Rhizoma Dioscoreae Bulbiferae: nature and flavor hardship, cold, return lung, Liver Channel, heat-clearing and toxic substances removing, eliminating stagnation removing heat from blood.(the same 2. 180 pages)
Flos Carthami: nature and flavor suffering, temperature, GUIXIN, Liver Channel, promoting blood circulation to restore menstrual flow, stasis-dispelling and pain-killing contains carthamin, Carthamus yellow etc., and the anticoagulant effect is arranged.(the same 1. 123 pages)
Radix Paeoniae Rubra: the nature and flavor hardship, be slightly cold, return Liver Channel, blood circulation promoting and blood stasis dispelling, clearing away heat and cooling blood contains Radix Paeoniae Rubra first element, second element, benzoic acid etc., anticoagulant is arranged and reduce the effect of fibrinogen level.(the same 1. 122 pages)
Semen Persicae: nature and flavor hardship, sweet, flat, GUIXIN, liver, large intestine channel, removing blood stasis contains amygdalin, fatty wet goods, and remarkable inhibition hemagglutinative function is arranged.(the same 1. 122 pages)
Rhizoma Chuanxiong: nature and flavor suffering, temperature, return liver, gallbladder, heart color warp, promoting flow of QI and blood, wind-expelling pain-stopping contains alkaloid, volatilization wet goods, can reduce plasma viscosity, and can directly expand peripheral vessels.(the same 1. 123 pages)
Radix Salviae Miltiorrhizae: the nature and flavor hardship, be slightly cold, GUIXIN, Liver Channel, blood circulation promoting and blood stasis dispelling contains TANSHINONES first, second, the third gradegrade C, can expand peripheral vessels, and anticoagulation and antiplatelet aggregative activity are arranged.(the same 1. 122 pages)
River Niu Xi: nature and flavor hardship, acid, flat, blood circulation promoting and blood stasis dispelling contains alkaloid etc., and the effect that improves erythrocyte deformability is arranged.(the same 1. 123-124 page or leaf)
Caulis Spatholobi: nature and flavor hardship, little sweet, warm, return liver, kidney channel, to enrich blood and invigorate blood circulation, channels sootheing and network vessel quickening contains milletol etc., and the effect of microcirculation improvement is arranged.(the same 1. 124-125 page or leaf)
Olibanum: nature and flavor suffering, hardship, temperature have promoting blood circulation and stopping pain, the effect of detumescence and promoting granulation.(the same 1. 125 pages)
Radix Angelicae Sinensis: nature and flavor are sweet, hot, warm, and GUIXIN, liver, spleen channel are enriched blood and invigorated blood circulation, and contain volatile oil, alkaloid etc., and the effect that reduces fibrinogen level is arranged.(the same 1. 132 pages)
Hirudo: nature and flavor become, hardship, flat, return Liver Channel, removing blood stasis, and hirudin has anticoagulation.(the same 2. 162 pages)
Eupolyphaga Seu Steleophaga: nature and flavor become, tremble with fear, and return Liver Channel, and removing blood stasis has the effect of microcirculation improvement.(the same 2. 161 pages)
Agkistrodon: nature and flavor are sweet, one-tenth, temperature, return Liver Channel, and dispelling, collateral-activating is favus malignant boil key medicine.(the same 2. 87 pages)
Scorpio: nature and flavor suffering, flat, return Liver Channel, the detoxicating and resolving stagnation of pathogens removing obstruction in the collateral to relieve pain, it is deep to wear muscle, removes the wind effect by wetting.(the same 2. 202 pages)
Radix Aconiti Lateralis Preparata: nature and flavor suffering, heat, GUIXIN, kidney, spleen channel, it is supporing yang to mend fire, and dispersing cold for relieving pain is controlled the cold weak effect of beriberi.(the same 2. 108 pages)
Placenta Hominis: nature and flavor are sweet, one-tenth, temperature, return lung, liver, kidney channel, mend smart, nourish blood, QI invigorating.(the same 2. 228 pages)
Sanguis Draxonis: nature and flavor are sweet, one-tenth, flat, GUIXIN, Liver Channel, and hemostasia and promoting granulation is held back skin ulcer, the promoting blood circulation to remove blood stasis pain relieving.(the same 2. 274 pages)
The Radix Astragali: sweet, the tepor of nature and flavor, return the spleen lung meridian, tonifying Qi and lifting yang, promoting pus discharge and tissue regeneration strengthening contains saccharide, choline etc., has antithrombotic to form, improve the effect of cutaneous circulation.(the same 1. 130 pages)
All medicines are synthetic, heat-clearing and toxic substances removing, and blood circulation promoting and blood stasis dispelling, promoting tissue regeneration and ulcer healing plays antiinflammatory, improves hemorheology, improves the effect of blood samples of patients circulation, thereby reaches the purpose of curing thromboangiitis obliterans.
Motherland's medical science has absorbed the organic conception theory of mutual generation of five phases restriction or checking relation in five elements in the Chinese ancient philosophy, think and on physiology and pathology, have confidential relation between the vital organs of the human body, this cacosplanchnia often causes the disease of other internal organs, the disease of other internal organs also can cause the pathological changes of these internal organs, and internal organs and extremity nine orifices are closely related on pathogenesis, various paathogenic factors interact, and finally cause the function disorder, disorder of QI and blood and disease takes place.Thromboangiitis obliterans belongs to " necrosis " category in the traditional Chinese medical science, due to, deficiency of the liver and kindey strong mainly due to temper, cold-damp invasion and attack, the venation that stagnates.Spleen kidney yang QI-insufficiency can not the replenishing vital QI with drugs of warm nature extremity, the heresy of summer sense cold-damp, coagulation of QI-blood then, meridians check, stagnation of QI and blood may bring about pain, the extremity QI and blood is not filled, and loses in moistening fosterly, and then skin and flesh is withered withered not flourish, deficiency of the liver and kindey, the strongly fragrant heat-transformation of a specified duration of cold-evil, noxious dampness contamination, the venation impatency, limb not depletion of blood is supported, and causes burned black necrosis, very then comes off.Pain is wasting QI-blood for a long time, causes QI and blood deficiency.
Chinese patent medicine of the present invention is a starting point with warming YANG to expel cold, promoting blood circulation to remove obstruction in the collateral, heat-clearing and toxic substances removing.At first set about from kidney warming and yang invigorating, medicinal Radix Aconiti Lateralis Preparata, Placenta Hominis, Radix Aconiti Lateralis Preparata are gone into the beer kidney channel, the sun of energy warming the spleen kidney, and dispersing cold for relieving pain, Placenta Hominis are returned the Liver and kidney warp, energy nourishing blood and invigorating qi, the warm logical foster extremity that moisten.The cold-evil stagnates, and QI and blood is obstructed, and then limbs pain is just used medicines such as Semen Persicae, Flos Carthami, Rhizoma Chuanxiong, Radix Polygoni Ciliinerve, the effect of playing promoting blood circulation, dredging meridian and relieving pain altogether unbearably.Poison is accumulate in the strongly fragrant heat-transformation of a specified duration of cold-evil, and evil poison contamination adds with Flos Lonicerae, Herba Patriniae, Herba Violae, with heat-clearing and toxic substances removing, and detumescence and apocenosis.More help with Agkistrodon, Scorpio expel wind to dredge collateral, eliminating stagnation disappears bitterly.The blood supply of limbs depletion of blood, and cause burned black necrosis, square with Sanguis Draxonis, promoting tissue regeneration and ulcer healing, eliminating stasis to stop pain.The disease of QI and blood deficiency appears in the sick impairment of QI of consumption for a long time blood, and heavily mend and instead easily stay heresy, thus with the Radix Astragali, Radix Angelicae Sinensis, make gas prosperous capable with short blood, blood stasis dispelling and just not hindering, the particularly Radix Astragali one thing energy evacuation of pus pain relieving, the hemopoietic of invigorating blood circulation, expelling the toxic substance from the body with tonic carbuncle of yin nature are persons particularly liable to develop skin infection's panacea in fact.All medicines share, and YIN-cold must be loose, and QI and blood must be logical, and are eliminating evil and just do not hinder, and QI invigorating is beneficial to evacuation of pus again, treating both the principal and secondary aspects of a disease, and cold and heat decompose, and all diseases will cancellation.
For showing the curative effect of Chinese patent medicine of the present invention, Chinese patent medicine of the present invention has been carried out clinical treatment this has been tested, according to statistical experiment group totally 180 examples, wherein: male 127 examples, women 53 examples, the age is at 22-67 between year, 42 years old mean age, medical history 8 months-3 years, average 1.6 years, Therapeutic Method was for taking Chinese patent medicine of the present invention, each 1 ball, every day 3 times, per 15 days was 1 course of treatment, and the mean treatment time was 14 courses of treatment; Matched group is totally 186 examples, wherein: male 119 examples, women 67 examples, the age is between 19-62 year, medical history 6 months-1.9 years, average 1.2 years, Therapeutic Method was for taking Western medicine, and as Ai Lasulin, the sour sheet etc. that looses, every day 3 times, the mean treatment time is 8 months.And it is as follows to formulate criterion of therapeutical effect:
Recovery from illness: transference cure, dorsal artery of foot or posterior tibial artery are beaten and are recovered normal, and the position test transfers feminine gender to, recovers former work, follows up a case by regular visits to 1-3, does not have recurrence.
Produce effects: clinical symptoms significantly alleviates, and rest pain and intermittent claudication disappear, and suffers from limb color of the leather and temperature and before is clearly better, and the more preceding obvious improvement of beating of instep and posterior tibial artery can be engaged in light work.
Take a turn for the better: the improvement of having beaten of pain relief, but still have slight rest pain, pain in foot and posterior tibial artery.
Invalid: symptom and sign do not have the improver.
The upright shelves of warp stay to be looked into and follow up survey, and carries out the statistical analysis contrast, and statistical result is as follows: table 1, test group curative effect situation
Table 2, matched group curative effect situation
From above-mentioned clinical treatment contrast test, picked at random 2 examples are further to show the therapeutic effect of Chinese patent medicine of the present invention.
Wu Xiulun, man 49 years old, Ma Lou township, Taiqian County, Henan Province Wu Lou people from village, the calendar year 2001 first visit was had a surplus for suffering from thromboangiitis obliterans in 1 year, and invalid through multi-treatment, the inventor locates to seek medical advice July calendar year 2001, the atrophy of Ipsilateral muscle of leg, instep portion skin is brown-black, and instep portion arteriopalmus disappears, halluces has 2 * 2 centimetres of depression ulcer, wound surface has more purulent secretion, and pain increases severely, and holds up turn and go, about 50 meters of every walkings along the street, pain is led capable shank, and night, the pain increased, takes Chinese patent medicine of the present invention, early, in, respectively obey 1 ball evening, 15 days was 1 course of treatment, took medicine pain relief through 5 courses of treatment, around the wound surface scarlet granulation that reveals, wound surface and central authorities be the point-like healing.Continuation clothes Chinese patent medicine of the present invention is totally 16 courses of treatment, the pain complete obiteration, and ulcer all heals, and recovery from illness is followed up a case by regular visits to, so far recurrence.
Gu Guangxiang, the man, 47 years old, Yanggu County Da Bu township secondary school teachers, Ipsilateral instep portion skin is livid purple color, the obvious atrophy of muscle of leg, instep portion arteriopalmus disappears.Instep, right side portion and five toe pain were had a surplus as cutting in 8 months, and night, unable to fall asleep often bent over to sit with one's arms about one's knees all night, and walking along the street is born a heavy burden, and the pain increased.Be diagnosed as thromboangiitis obliterans by certain Affiliated Hospital of medical college institute, hospitalization, and do the artery bypass art, invalid.In August, 1999, oral medicine of the present invention, every day 3 times, each 1 ball, per 15 days was 1 course of treatment, take medicine 4 courses of treatment, pain relief, instep portion skin color has clear improvement, and continues to obey 12 courses of treatment by former side, and recovery from illness is followed up a case by regular visits to, so far recurrence.
Below in conjunction with most preferred embodiment Chinese patent medicine of the present invention is described in further detail.
Get Radix Astragali 30g, Agkistrodon 10g, Scorpio 6g, Rhizoma Dioscoreae Bulbiferae 12g, Flos Carthami 12g, Semen Persicae 15g, Rhizoma Chuanxiong 12g, Radix Paeoniae Rubra 12g, Flos Lonicerae 20g, Placenta Hominis 20g, Radix Angelicae Sinensis 20g, river cattle sunset 12g, Hirudo 6g, Radix Glycyrrhizae 12g, Radix Aconiti Lateralis Preparata 6g, Radix Scrophulariae 15g, Radix Salviae Miltiorrhizae 20g, Semen Coicis 20g, Caulis Spatholobi 12g, Eupolyphaga Seu Steleophaga 12g, Sanguis Draxonis 6g, Olibanum 9g, Herba Violae 20g, Herba Patriniae 20g, with the said medicine mix homogeneously, grind to form smalls, thin square-bottomed bamboo basket sieving, make honeyed pill, every ball 9g, each 1 ball, every day 3 times, 15 days is 1 course of treatment, state of an illness weight person serve on 16-23 the course of treatment, can effectively treat thromboangiitis obliterans.
Claims (2)
1, a kind of Chinese patent medicine for the treatment of thromboangiitis obliterans is characterized in that: it is by the formulated Chinese patent medicine of the raw material of Chinese medicine of the various compositions of following weight proportioning
Radix Astragali 30-50 part, Agkistrodon 6-15 part, Scorpio 2-6 part, Rhizoma Dioscoreae Bulbiferae 10-20 part,
Flos Carthami 6-12 part, Semen Persicae 12-20 part, Rhizoma Chuanxiong 10-15 part, Radix Paeoniae Rubra 10-15 part,
Flos Lonicerae 20-30 part, Placenta Hominis 15-20 part, Radix Angelicae Sinensis 10-30 part, river cattle sunset 10-12 part,
Hirudo 3-6 part, Radix Glycyrrhizae 9-12 part, Radix Aconiti Lateralis Preparata 6-8 part, Radix Scrophulariae 10-20 part,
Radix Salviae Miltiorrhizae 20-40 part, Semen Coicis 20-30 part, Caulis Spatholobi 12-15 part, Eupolyphaga Seu Steleophaga 12-15 part,
Sanguis Draxonis 6-9 part, Olibanum 5-9 part, Herba Violae 20-40 part, Herba Patriniae 12-20 part.
2, the Chinese patent medicine of treatment thromboangiitis obliterans as claimed in claim 1 is characterized in that: the optimum weight proportioning of the former medicine of Chinese medicine of various compositions is
Radix Astragali 30g, Agkistrodon 10g, Scorpio 6g, Rhizoma Dioscoreae Bulbiferae 12g, Flos Carthami 12g,
Semen Persicae 15g, Rhizoma Chuanxiong 12g, Radix Paeoniae Rubra 12g, Flos Lonicerae 20g, Placenta Hominis 20g,
Radix Angelicae Sinensis 20g, river cattle sunset 12g, Hirudo 6g, Radix Glycyrrhizae 12g, Radix Aconiti Lateralis Preparata 6g,
Radix Scrophulariae 15g, Radix Salviae Miltiorrhizae 20g, Semen Coicis 20g, Caulis Spatholobi 12g, Eupolyphaga Seu Steleophaga 12g,
Sanguis Draxonis 6g, Olibanum 9g, Herba Violae 20g, Herba Patriniae 20g.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021357390A CN1211108C (en) | 2002-10-25 | 2002-10-25 | Chinese patent drug for treating thrombus obliterating angiitis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB021357390A CN1211108C (en) | 2002-10-25 | 2002-10-25 | Chinese patent drug for treating thrombus obliterating angiitis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1413722A true CN1413722A (en) | 2003-04-30 |
CN1211108C CN1211108C (en) | 2005-07-20 |
Family
ID=4748330
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB021357390A Expired - Fee Related CN1211108C (en) | 2002-10-25 | 2002-10-25 | Chinese patent drug for treating thrombus obliterating angiitis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1211108C (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011493B (en) * | 2007-01-16 | 2010-12-08 | 李丰举 | Angiitis granule and its preparation method |
CN101711813B (en) * | 2009-11-11 | 2012-01-11 | 宋爱民 | Traditional Chinese medicine pill for treating vasculitis |
CN102406743A (en) * | 2011-11-23 | 2012-04-11 | 朱法存 | Traditional Chinese preparation for treating cerebral thrombosis |
CN101380391B (en) * | 2008-09-11 | 2012-05-23 | 刘湘秋 | Traditional Chinese medicine external application paste for treating angiitis |
CN101199658B (en) * | 2007-12-19 | 2012-07-18 | 李华君 | Chinese medicine compound for oral administration for treating vasculitis |
CN104666780A (en) * | 2015-02-10 | 2015-06-03 | 青岛市中心医院 | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans |
CN104800302A (en) * | 2015-03-30 | 2015-07-29 | 奚济孝 | Externally applied plaster for treating thromboangiitis obliterans and preparation method |
CN105709155A (en) * | 2016-05-03 | 2016-06-29 | 魏忠 | Traditional Chinese medicine for treating thromboangiitis obliterans |
CN106138702A (en) * | 2016-09-12 | 2016-11-23 | 防城港思创信息技术有限公司 | Inflammation diminishing and blood circulation promoting soup for thrombophlebitis |
-
2002
- 2002-10-25 CN CNB021357390A patent/CN1211108C/en not_active Expired - Fee Related
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101011493B (en) * | 2007-01-16 | 2010-12-08 | 李丰举 | Angiitis granule and its preparation method |
CN101199658B (en) * | 2007-12-19 | 2012-07-18 | 李华君 | Chinese medicine compound for oral administration for treating vasculitis |
CN101380391B (en) * | 2008-09-11 | 2012-05-23 | 刘湘秋 | Traditional Chinese medicine external application paste for treating angiitis |
CN101711813B (en) * | 2009-11-11 | 2012-01-11 | 宋爱民 | Traditional Chinese medicine pill for treating vasculitis |
CN102406743A (en) * | 2011-11-23 | 2012-04-11 | 朱法存 | Traditional Chinese preparation for treating cerebral thrombosis |
CN102406743B (en) * | 2011-11-23 | 2015-06-24 | 朱法存 | Traditional Chinese preparation for treating cerebral thrombosis |
CN104666780A (en) * | 2015-02-10 | 2015-06-03 | 青岛市中心医院 | Traditional Chinese medicinal preparation for treating thromboangiitis obliterans |
CN104800302A (en) * | 2015-03-30 | 2015-07-29 | 奚济孝 | Externally applied plaster for treating thromboangiitis obliterans and preparation method |
CN105709155A (en) * | 2016-05-03 | 2016-06-29 | 魏忠 | Traditional Chinese medicine for treating thromboangiitis obliterans |
CN106138702A (en) * | 2016-09-12 | 2016-11-23 | 防城港思创信息技术有限公司 | Inflammation diminishing and blood circulation promoting soup for thrombophlebitis |
Also Published As
Publication number | Publication date |
---|---|
CN1211108C (en) | 2005-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100341545C (en) | Oral medicine for treating thromboangitis obliterans | |
CN102319327A (en) | Traditional Chinese medicine for internally and externally treating diabetic foot | |
CN102697939B (en) | Traditional Chinese medicine foot bath solution for preventing diabetic foot and preparation method thereof | |
CN102178800A (en) | Chinese medicine composition for treating rheumatoid arthritis and preparation method thereof | |
CN103263488A (en) | Chinese medicine fumigation-washing decoction for treating capecitabine extremities syndrome | |
CN107693767A (en) | A kind of external medicine composition, its preparation method and application for preventing and treating diabetes | |
CN102100754A (en) | Chinese medicinal composition for treating osteoproliferation | |
CN102861287B (en) | Chinese medicinal composition for treating damp-heat invasion blood stasis diabetic foot and preparation method thereof | |
CN1211108C (en) | Chinese patent drug for treating thrombus obliterating angiitis | |
CN100536886C (en) | External-applied traditional Chinese medicine composition for treating gout | |
CN102772712B (en) | Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot | |
CN102357220B (en) | Traditional Chinese medicine composition for treating early-stage lower limb thrombotic deep phlebitis | |
CN104324340B (en) | It is a kind of to treat Chinese medicine preparation of heel bone hyperosteogeny and preparation method thereof | |
CN107929457A (en) | A kind of Chinese medicine composition and preparation method for treating rheumatic arthritis | |
CN1247233C (en) | Chinese medicine for varicose vein | |
CN104043038A (en) | Medicinal preparation used for treating early-stage diabetic foot | |
CN103977113A (en) | Traditional Chinese medicament for treating diabetic foot | |
CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
CN103585483B (en) | Traditional Chinese medicine composition for treating knee osteoarthritis and preparation method of same | |
CN112043799A (en) | Oral medicine for treating gout and preparation method thereof | |
CN105561272A (en) | Traditional Chinese medicine preparation for relieving Reynolds disease and preparation method thereof | |
CN110478416A (en) | The composition and its preparation method and application for treating rheumatic rheumatoid arthritis | |
CN104306734B (en) | Treat diabetic gangrene externally applied ointment preparation and preparation method thereof | |
CN104324108B (en) | External-use traditional Chinese medicine composition for treating knee osteoarthritis (arthralgia syndrome) | |
CN102861161B (en) | Method for preparing traditional Chinese medicine wet tissue for treating scale keratosis type tinea manus and tinea pedis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C19 | Lapse of patent right due to non-payment of the annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |